Live corpus
Active intelligence prompt Pediatric cancer: surface high-value therapeutic signals across pediatric oncology literature.
PEDIATRIC CANCER RESEARCH INTELLIGENCE

Finding therapies hidden in 39,947 pediatric cancer papers.

Neurocompute scores pediatric oncology literature, surfaces overlooked therapeutic signals, and turns fragmented childhood cancer research into a living discovery terminal.

39,947 Papers indexed
1,440 Papers AI scored
39,947 Ranked papers
100.0% Coverage
PATIENT-FRIENDLY SUMMARY

CHIP-AML22: a complex clinical trial in de novo pediatric AML patients, including a gemtuzumab ozogamicin randomization and targeted therapy with quizartinib in eligible subgroups, within the NOPHO-DB-SHIP consortium.

For education only—not personal medical advice.

LIVE PEDIATRIC ONCOLOGY INTELLIGENCE
↑ Therapeutic signals emerging ↑ New pediatric cancer papers ingested ↑ Cross-paper convergence detected ↑ Human relevance scores updating ↑ Overlooked treatment paths surfacing
TOP PEDIATRIC CANCER SIGNALS

Ranked Discovery Journal Articles

View all discoveries →
PEDIATRIC CANCER RESEARCH TERMINAL

All ranked pediatric cancer papers

39947 results
C
Multi‑omics identification of MSI2 as a super-enhancer‑driven vulnerability in MYCN‑amplified neuroblastoma.
PMID 42143291 Published: 2026-05-16 Ingested: 2026-08-02 12:06 AM Journal of translational medicine
AI -
Standard 58.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 58.0/100. Study design: 50.0; human relevance: 55.0; therapeutic relevance: 50.0; sample size: 20.0; recency: 100.0; abstract quality: 100.0.

AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 58.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 20.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

C
The future of targeted therapies for pediatric central nervous system tumors.
PMID 42137218 Published: 2025-12-02 Ingested: 2026-08-02 12:05 AM Neuro-oncology advances
AI -
Standard 58.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 58.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 30.0; sample size: 20.0; recency: 100.0; abstract quality: 65.0.

C
AI -
Standard 58.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 58.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 30.0; sample size: 20.0; recency: 100.0; abstract quality: 65.0.

C
Analysis of Functional Outcomes and Donor Site Morbidity Following Fibula Flap Harvest in the Skeletally Immature Patient Population.
PMID 42112807 Published: 2026-05-11 Ingested: 2026-08-02 12:07 AM Plastic and reconstructive surgery
AI -
Standard 58.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 58.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 40.0; recency: 100.0; abstract quality: 85.0.

C
AI -
Standard 58.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 58.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 20.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

C
AI -
Standard 58.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 58.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 20.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

C
Adult and pediatric cystic nephroma: an easily misdiagnosed renal tumor.
PMID 42109676 Published: 2026-04-23 Ingested: 2026-08-02 12:06 AM Frontiers in oncology
AI -
Standard 58.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 58.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 20.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

C
Development of the Korean Version of the Children's Palliative Care Outcome Scale.
PMID 42107851 Published: 2026-05-08 Ingested: 2026-08-02 12:06 AM Journal of pain and symptom management
AI -
Standard 58.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 58.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 40.0; recency: 100.0; abstract quality: 85.0.

C
Rare Pediatric Venolymphatic Malformations: Pericardial Cyst Mimickers.
PMID 42101406 Published: 2026-05-07 Ingested: 2026-08-02 12:06 AM JACC. Case reports
AI -
Standard 58.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 58.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 20.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

C
AI -
Standard 58.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 58.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 15.0; sample size: 30.0; recency: 100.0; abstract quality: 85.0.

C
Patterns of Endogenous Nasal Colonization and Bloodstream Isolates in Pediatric Leukemia with Healthcare-Associated Infections in Indonesia.
PMID 42084886 Published: 2026-05-04 Ingested: 2026-08-02 12:07 AM Turkish archives of pediatrics
AI -
Standard 58.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 58.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 40.0; recency: 100.0; abstract quality: 85.0.

Previous
Page 2167 of 3329
Next
Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic